Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinge Zhao

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Translational Cancer Research|February 4, 2022
MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8Pengfei Shen, Guangxi Sun, Peng Zhao, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 24, 2023
Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysisHong Zeng, Jindong Dai, Dehong Cao, et al.
The Journal of Pathology. Clinical Research|January 14, 2026
Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancerQiyu Zhu, Yifu Shi, Ting Wang, et al.
The Journal of Urology|January 18, 2019
The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate CancerJinge Zhao, Jiandong Liu, Guangxi Sun, et al.
Journal of Cancer|October 2, 2018
Improved Long-Term Clinical Outcomes And Safety Profile Of Sunitinib Dosing Schedule With 4/2 Switched To 2/1 In Patients With Metastatic Renal Cell CarcinomaXingming Zhang, Guangxi Sun, Jinge Zhao, et al.
World Journal of Urology|August 23, 2024
Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/mlHong Zeng, Yuntian Chen, Jinge Zhao, et al.
ACS Applied Bio Materials|February 14, 2022
Electrochemical DNA Biosensors Based on the Intrinsic Topological Insulator BiSbTeSe<sub>2</sub> for Potential Application in HIV DeterminationYujiu Jiang, Shanshan Li, Peng Zhu, et al.
World Journal of Surgical Oncology|February 26, 2020
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysisZhipeng Wang, Yuchao Ni, Junru Chen, et al.
The Prostate|July 29, 2017
The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomyGuangxi Sun, Rui Huang, Xingming Zhang, et al.
Frontiers in Oncology|December 16, 2020
Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based AnalysisJunru Chen, Yuchao Ni, Guangxi Sun, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Translational Cancer Research|February 4, 2022
MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8Pengfei Shen, Guangxi Sun, Peng Zhao, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 24, 2023
Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysisHong Zeng, Jindong Dai, Dehong Cao, et al.
The Journal of Pathology. Clinical Research|January 14, 2026
Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancerQiyu Zhu, Yifu Shi, Ting Wang, et al.
The Journal of Urology|January 18, 2019
The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate CancerJinge Zhao, Jiandong Liu, Guangxi Sun, et al.
Journal of Cancer|October 2, 2018
Improved Long-Term Clinical Outcomes And Safety Profile Of Sunitinib Dosing Schedule With 4/2 Switched To 2/1 In Patients With Metastatic Renal Cell CarcinomaXingming Zhang, Guangxi Sun, Jinge Zhao, et al.
World Journal of Urology|August 23, 2024
Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/mlHong Zeng, Yuntian Chen, Jinge Zhao, et al.
ACS Applied Bio Materials|February 14, 2022
Electrochemical DNA Biosensors Based on the Intrinsic Topological Insulator BiSbTeSe<sub>2</sub> for Potential Application in HIV DeterminationYujiu Jiang, Shanshan Li, Peng Zhu, et al.
World Journal of Surgical Oncology|February 26, 2020
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysisZhipeng Wang, Yuchao Ni, Junru Chen, et al.
The Prostate|July 29, 2017
The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomyGuangxi Sun, Rui Huang, Xingming Zhang, et al.
Frontiers in Oncology|December 16, 2020
Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based AnalysisJunru Chen, Yuchao Ni, Guangxi Sun, et al.
Pageof 10